comparemela.com


Here’s Why Baron Funds Became Bullish in Bio-Techne Corp. (TECH)
Baron Funds, an asset management firm, published its “Baron Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 0.94% was delivered by the fund’s institutional shares for the Q1 of 2021, trailing its primary benchmark, the Russell 2000 Growth Index, that rose to 4.88% and the S&P 500 Index that delivered a 6.17% return for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Baron Growth Fund, in its Q1 2021 investor letter, mentioned Bio-Techne Corporation (NASDAQ: TECH), and shared their insights on the company. Bio-Techne Corporation is a Minneapolis, Minnesota-based biotechnology company that currently has a $15.9 billion market capitalization. Since the beginning of the year, TECH delivered a 28.76% return, extending its 12-month gains to 56.16%. As of May 12, 2021, the stock closed at $408.88 per share.

Related Keywords

Minnesota ,United States , ,Federal Reserve ,Baron Growth Fund ,Bio Techne Corporation ,Baron Funds ,Growth Fund ,Techne Corporation ,With Highest Medical Research Spending ,Popular Stocks Among Hedge ,Insider Monkey ,Free Daily Newsletter ,மினசோட்டா ,ஒன்றுபட்டது மாநிலங்களில் ,கூட்டாட்சியின் இருப்பு ,பரோன் வளர்ச்சி நிதி ,உயிர் தொழில்நுட்பம் நிறுவனம் ,பரோன் நிதி ,வளர்ச்சி நிதி ,தொழில்நுட்பம் நிறுவனம் ,உடன் மிக உயர்ந்தது மருத்துவ ஆராய்ச்சி செலவு ,பாப்யுலர் ஸ்டாக்ஸ் மத்தியில் ஹெட்ஜ் ,உள் குரங்கு ,இலவசம் தினசரி செய்திமடல் ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.